Colgate-Palmolive India was up 0.57% to Rs 380.25 on registering 68.82% growth in net profit in Q1 June 2007. The results were announced in the market hours today, 27 July 2007.
Broking house, P-Sec recommended hold rating on Thermax.
P-Sec report on Thermax:
Thermax reported a growth of 107% yoy and a bottom line growth of 103% yoy. The results bettered our expectations with a big margin, the EBITDA margins sank by 38 bps yoy. The management had given a rich guidance of 40% yoy growth for FY08 and have maintained there position of stable to better margins.
The current order book stands at Rs. 36.72bln (0up by 66%yoy) that is 1.42x net sales of FY07 offering visibility for future growth.
Ranbaxy Laboratories leads the gainers path on the Sensex. In morning trades, the share is quoting at Rs 364.40, which is up Rs 23.35, or 6.85%.
It touched an intraday high of Rs 365.50 and an intraday low of Rs 340 during the day.
Today, the scrip is trading with volumes of 523,094 shares. Yesterday the share ended the day on a dreary note after losing 1.02% or Rs 3.50 at Rs 341.05.
, P-Sec recommended hold rating on Thermax. 
In early trades, Industrial Finance
Ranbaxy Laboratories leads the gainers path on the Sensex. In morning trades, the share is quoting at Rs 364.40, which is up Rs 23.35, or 6.85%. 
is expecting Kewal Kiran Clothing and rec
Blue Star increased 5.59% to Rs 266.50 in afternoon trades after its net profit zoomed 205.7
